BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell) / Sinopharm - LARVOL DELTA

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above (clinicaltrials.gov) - P3 | N=4200 | Active, not recruiting | Sponsor: China National Biotec Group Company Limited | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Novel Coronavirus Disease

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (clinicaltrials.gov) - P1/2 | N=280 | Active, not recruiting | Sponsor: China National Biotec Group Company Limited | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2023 ➔ Oct 2023 | Trial primary completion date: Oct 2022 ➔ Oct 2023

Enrollment closed • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above (clinicaltrials.gov) - P3 | N=1750 | Not yet recruiting | Sponsor: Sinovac Research and Development Co., Ltd.

New P3 trial • Infectious Disease • Novel Coronavirus Disease

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above (clinicaltrials.gov) - P3 | N=4200 | Recruiting | Sponsor: China National Biotec Group Company Limited

New P3 trial • Infectious Disease • Novel Coronavirus Disease